Product Code: RP-ID-10293955 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Healthcare & Pharmaceuticals |
Report ID: 10293955
Market Overview:
Cancer Therapeutics Market, By Types (Prostate Cancer, Blood Cancer, Lung Cancer, Skin Cancer, Gastrointestinal Cancer, Breast Cancer, And Others), By Therapy (Chemotherapy, Hormonal, Immunotherapy, Targeted Therapy And Other) And Geography (North America, Europe, Asia Pacific, And Rest Of The World) – Analysis, Share, Trends, Size, & Forecast From 2014 – 2025
REPORT HIGHLIGHT
The “Global Cancer Therapeutics Market- – Industry Analysis, Share, Trend, Market Size and Forecast” was estimated to be around US$ 98.0 billion in 2016 and is anticipated to grow with 10.0% of growth rate during the future period. This report segments the global Cancer Therapeutics Market by types, therapy and geography. This report covers the detailed study of commercially available cancer drugs for geographies such as North America, Europe, Asia Pacific, Meddle East & Africa and South America. Cancer is one of the most prevalent chronic diseases, affecting millions of population worldwide every year. The surge in innovation in cancer treatment and rising demand for cancer related therapeutics has cached attention of many cancer patients to provide effective cancer therapeutics. Types segment is primarily categorized into prostate cancer, blood cancer, lung cancer, skin cancer, gastrointestinal cancer, breast cancer, and other cancer types. f the different type’s segment, blood cancer, and breast cancer types are accounted for the majority share of the global market revenue. Rise in incidence of blood and breast cancer coupled with increasing demand for novel therapeutics in this segment drives the market growth. However, prostate cancer segment is projected to grow with the highest CAGR of 11.8% during the forecast period.
The market size and forecast for each segment has been provided for the period 2014 to 2025, considering 2015 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2016 to 2025 for every reported segment.
The report aims at estimating the market size and future growth potential of market across different segments, such as types, therapy and regions. The years considered for the study are:
Historical Year – 2014 & 2015
Base Year – 2015
Estimated Year – 2016
Projected Year – 2025
Companies reported in this report are: F. Hoffmann-La Roche, Novartis AG, Johnson and Johnson, Pfizer Inc., Sanofi SA, Merck & Co., Inc, GlaxoSmithKline plc, Eli Lilly and Company and Others. For company profiles in the report, 2014 has been considered. Where information is unavailable for the base year, the prior year has been considered.
TARGET AUDIENCE
Hospitals
Manufacturers
Traders, Distributors, And Suppliers of Cancer Drugs
Government and Regional Agencies and Research Organizations
Consultants
Distributors
SCOPE OF THE REPORT
The research report categorizes the Cancer Therapeutics Market in each of the following submarkets to forecast the revenues and analyze the trends:
GLOBAL CANCER THERAPEUTICS MARKET, BY TYPES
Prostate Cancer
Blood Cancer
Lung Cancer
Skin Cancer
Gastrointestinal Cancer
Breast Cancer
Others
GLOBAL CANCER THERAPEUTICS MARKET, BY THERAPY
Chemotherapy
Hormonal
Immunotherapy
Targeted Therapy
Others
GLOBAL CANCER THERAPEUTICS MARKET, BY REGION
North America
Europe
Asia Pacific
Rest of the World
GLOBAL CANCER THERAPEUTICS MARKET, GEOGRAPHIC ANALYSIS
Further Breakdown of The North America Cancer Therapeutics Market
S.
Canada
Further Breakdown of The Europe Cancer Therapeutics Market
Germany
France
Rest of Europe
Further Breakdown of The APAC Cancer Therapeutics Market
India
China
Rest of APAC
Further Breakdown of The Rest of the World Cancer Therapeutics Market
Middle East and Africa
Latin America
Related Reports
Proof of Quality & Reliability
